Find VeraSci at these Conferences and Events

International Society for CNS Clinical Trials and Methodology (ISCTM) 2020 Autumn Conference

| September 21st-25th 2020

Dr. Rich Keefe, CEO of VeraSci will co-chair the Virtual Hot Topics session "Regulatory Viewpoints From EMA and FDA on Contemporary Challenges and Strategies for Conducting and Analyzing Clinical Trials in the COVID-19 Era" along with Dr. Mike Davis and Dr. Valentina Mantua from FDA and several panelists from FDA and the European Medicines Agency.

Read More

NAN | National Academy of Neuropsychology Virtual Conference 2020

Online | October 14th-16th 2020

Dr. Kathleen Welsh-Bohmer of VeraSci will be a featured speaker during the 2020 National Academy of Neuropsychology Virtual Conference. Her presentation "Diagnosing Early Stage Pre-Clinical Alzheimer's Disease" will include discussing clinical advances and ethical considerations of the prevention and treatment of Alzheimer's Disease.

Read More

CTAD | Clinical Trials in Alzheimer’s Disease 2020

Boston, USA | November 4th-7th 2020

VeraSci will be attending CTAD 2020, on November 4-7. Clinical trial teams from worldwide centers will report on their efforts to identify new biomarkers of disease as well as more sensitive clinical assessment tools to identify those at risk for AD, to predict progression, and assess the effectiveness of new treatments.  We look forward to meeting with you in Boston!

Read More

AARR | Alzheimer’s Association Reasearch Roundtable 2020

Washington, DC | December 1st-2nd 2020

VeraSci is participating in the Alzheimer's Association Research Roundtable (AARR) annual meeting on December 1-2,  in Washington D.C.

Read More